A high court decision kept mifepristone available for now, but the legal battle continues.
Related posts:
Feds rethink vaccination strategy as slowing demand reveals stark divide
Rep. McCaul: Covid origin ‘worst cover-up in human history’
Confusion over Covid-19 boosters lingers as states roll out shots
U.S. to defer 33M Covid vaccine doses to Africa
Dems’ drug pricing dreams crash into reality in social spending tumult
Pfizer asks FDA to authorize Covid shot for children under 5
Biden’s relaunched cancer moonshot needs funding for liftoff
‘I almost lost my baby’: Parents demand answers from FDA
Global abortion-rights advocates worry their countries are next if Roe falls
FDA advisers endorse emergency use of Moderna Covid-19 vaccine in babies, toddlers
‘We can win’: Whitmer repeals Michigan’s 1931 abortion ban
Texas judge halts FDA approval of abortion pill
